ES545170A0 - Un procedimiento para la preparacion de amidas de aminoacido con actividad antitumoral. - Google Patents

Un procedimiento para la preparacion de amidas de aminoacido con actividad antitumoral.

Info

Publication number
ES545170A0
ES545170A0 ES545170A ES545170A ES545170A0 ES 545170 A0 ES545170 A0 ES 545170A0 ES 545170 A ES545170 A ES 545170A ES 545170 A ES545170 A ES 545170A ES 545170 A0 ES545170 A0 ES 545170A0
Authority
ES
Spain
Prior art keywords
amino acid
acid amides
procedure
preparation
antitumoral activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES545170A
Other languages
English (en)
Other versions
ES8703830A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of ES8703830A1 publication Critical patent/ES8703830A1/es
Publication of ES545170A0 publication Critical patent/ES545170A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
ES545170A 1984-07-13 1985-07-12 Un procedimiento para la preparacion de amidas de aminoacido con actividad antitumoral. Expired ES8703830A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59145731A JPH0662529B2 (ja) 1984-07-13 1984-07-13 アミノ酸誘導体

Publications (2)

Publication Number Publication Date
ES8703830A1 ES8703830A1 (es) 1987-03-01
ES545170A0 true ES545170A0 (es) 1987-03-01

Family

ID=15391835

Family Applications (3)

Application Number Title Priority Date Filing Date
ES545170A Expired ES8703830A1 (es) 1984-07-13 1985-07-12 Un procedimiento para la preparacion de amidas de aminoacido con actividad antitumoral.
ES557196A Expired ES8801185A1 (es) 1984-07-13 1986-11-13 Un procedimiento para la preparacion de amidas de aminoacido con actividad antitumoral
ES557197A Expired ES8801186A1 (es) 1984-07-13 1986-11-13 Un procedimiento para la preparacion de amidas de aminoacido con actividad antitumoral

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES557196A Expired ES8801185A1 (es) 1984-07-13 1986-11-13 Un procedimiento para la preparacion de amidas de aminoacido con actividad antitumoral
ES557197A Expired ES8801186A1 (es) 1984-07-13 1986-11-13 Un procedimiento para la preparacion de amidas de aminoacido con actividad antitumoral

Country Status (7)

Country Link
US (1) US4904680A (es)
EP (1) EP0173441B1 (es)
JP (1) JPH0662529B2 (es)
AT (1) ATE49749T1 (es)
CA (1) CA1283917C (es)
DE (1) DE3575554D1 (es)
ES (3) ES8703830A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01250370A (ja) * 1987-12-23 1989-10-05 Zeria Pharmaceut Co Ltd 新規アミノ酸イミド誘導体、製法ならびに用途
FR2646847B1 (fr) * 1989-05-12 1991-07-12 Rhone Poulenc Sante N-phenyl amides, leurs procedes de preparation et les medicaments les contenant
JPH0524090U (ja) * 1991-09-20 1993-03-30 仲秋 張 ジグソーパズル
HU211995B (en) * 1992-06-30 1996-01-29 Gyogyszerkutato Intezet Process to prepare novel benzoyl amino acid derivs. and pharmaceutical compns. contg.them
US5854250A (en) * 1995-10-11 1998-12-29 Gyogyszerkutato Intezet Kft N-benzoylamino acid derivatives, pharmaceutical compositions containing them and process of preparing same
KR20010012321A (ko) * 1997-05-07 2001-02-15 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. 신규의 시스테인 유도체, 이의 제조 방법 및 이를 함유한약제
JP4524039B2 (ja) * 1997-12-18 2010-08-11 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド Srcファミリーsh2ドメインインヒビターとしてのピリドン
US7427496B2 (en) * 1999-06-25 2008-09-23 The Regents Of The University Of Colorado Anti-cancer compounds
CA2401749A1 (en) 2000-03-23 2001-09-27 Elan Pharmaceuticals, Inc. Compounds and methods to treat alzheimer's disease
CA2410972A1 (en) 2000-06-30 2002-01-10 Elan Pharmaceuticals, Inc. Compounds to treat alzheimer's disease
ZA200406763B (en) * 2002-03-28 2005-09-30 Applied Research Systems Thiazolidine carboxamide derivatives as modulatorsof the prostaglandin F receptor.
DE102005028492A1 (de) * 2005-06-20 2006-12-28 Basf Ag Verfahren zur Herstellung von optisch aktiven Aminoalkylphenolen
MX2020002696A (es) 2017-09-13 2020-09-25 Amgen Inc Compuestos de bisamida que activan el sarcomero y sus usos.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE213641C (es) *
DE1236519B (de) * 1959-09-19 1967-03-16 Nippon Shinyaku Co Ltd Verfahren zum Herstellen eines analgetisch wirksamen Salicylsaeure-Derivates
DE1793613A1 (de) * 1966-05-13 1971-09-02 Francia Farma gamma-Orthohydroxybenzamidbutyramid
CH513123A (de) * 1967-09-25 1971-09-30 Bayer Ag Verfahren zur Herstellung von N-Acyl-a-aminosäureamiden bzw. -peptiden
IE33790B1 (en) * 1968-06-04 1974-10-30 Beecham Group Ltd Derivatives of n-acylaminoacid amides
DE2139641A1 (de) * 1971-08-07 1973-02-15 Bayer Ag 2-(p-chlorbenzoylamino)-carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
AU518147B2 (en) * 1976-12-03 1981-09-17 E.R. Squibb & Sons, Inc. Derivatives of thiazolidine, thiazine and morpholine carboxylic acids
EP0059536B1 (en) * 1981-03-04 1987-04-22 Imperial Chemical Industries Plc Amide derivatives, processes for preparing them, their use as fungicides and pesticidal compositions containing them

Also Published As

Publication number Publication date
ES8703830A1 (es) 1987-03-01
EP0173441A1 (en) 1986-03-05
ES557197A0 (es) 1988-01-01
ES557196A0 (es) 1988-01-01
ES8801186A1 (es) 1988-01-01
JPH0662529B2 (ja) 1994-08-17
DE3575554D1 (de) 1990-03-01
ATE49749T1 (de) 1990-02-15
CA1283917C (en) 1991-05-07
JPS6124550A (ja) 1986-02-03
ES8801185A1 (es) 1988-01-01
US4904680A (en) 1990-02-27
EP0173441B1 (en) 1990-01-24

Similar Documents

Publication Publication Date Title
ATE46539T1 (de) Cystein-verminderte muteine von interferon-beta, ihre herstellung, zusammensetzungen, die diese muteine enthalten sowie strukturgene, vektoren und organismen geeignet zur verwendung bei der herstellung der genannten muteine und deren herstellung.
IL95691A0 (en) Thienylcarboxylates of amino alcohols,their preparation and pharmaceutical compositions containing them
ES552627A0 (es) Procedimiento para la preparacion de carbamatos de fenilo
ES2040208T3 (es) Pirazolinas insecticidas.
IL76454A0 (en) Diarylacetylenes,their preparation and pharmaceutical compositions containing them
BR8600428A (pt) Compostos heterociclicos,processo para sua preparacao,composicoes inseticidas,processo para combate a insetos daninhos,utilizacao e processo para a preparacao de composicoes
ES557196A0 (es) Un procedimiento para la preparacion de amidas de aminoacido con actividad antitumoral
IT1228288B (it) Composti ad attivita' antiserotoninica
IL76456A (en) 1-substituted tetralin derivatives,their preparation and pharmaceutical compositions containing them
ES2128313T3 (es) Naftalimidas n-substituidas, su obtencion y empleo.
IT1216104B (it) Peptidi ad attivita' farmaceutica.
ES8401946A1 (es) Procedimiento para la preparacion de sulfonilureas.
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
IL77009A0 (en) Biphenylyloxy and biphenylylalkoxy aryl acyl urea derivatives,processes for the preparation thereof and pesticidal compositions containing the same
ES8303306A1 (es) "un procedimiento para preparar derivados de urea y tiourea".
HUT42065A (en) Insecticides and acaricides containing as active substance tetramethil-cycloprophan carbonic acid esthers and process for production thereof and their intermediers
NO910933D0 (no) Nytt pentapeptid og fremgangsmaate for fremstilling derav.
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
ES527308A0 (es) Procedimiento para la preparacion de derivados de benzazepina
ATE97130T1 (de) 13-brom und 13, 14-dibrom-ergoline, ihre herstellung und verwendung in arzneimitteln.
ES548790A0 (es) Un procedimiento para preparar diazohidroxidos de pirazina.
IT1216103B (it) Peptidi ad attivita' farmaceutica.
ES8107189A1 (es) Procedimiento para la preparacion de sulfonilureas
PH25608A (en) 3-amino-tetrahydro-isoquinoline
TH1781A (th) อนุพันธุ์ของกรดอัลเคนไทโอคาร์บ๊อกซิลิค ที่มีกลุ่มแทนที่

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970612